Safety of ipilimumab in patients (pts) with untreated, advanced melanoma alive beyond 2 years: Results from a phase III study.

被引：0

作者：

Thomas, Luc

Wolchok, Jedd D.

Garbe, Claus

Lebbe, Celeste

Bondarenko, Igor

Rodrigues, Kristen

Konto, Cyril

Chin, Kevin M.

Francis, Stephen

Robert, Caroline

机构：

[1] Univ Lyon 1, Ctr Hosp Lyon Sud, Pierre Benite, France

[2] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA

[3] Univ Med Ctr, Tubingen, Germany

[4] St Louis Hosp, Paris, France

[5] Dnepropetrovsk State Med Ctr, Dnepropetrovsk, Ukraine

[6] Bristol Myers Squibb Co, Wallingford, CT 06492 USA

[7] Bristol Myers Squibb Co, Braine Lalleud, Belgium

[8] Inst Gustave Roussy, Villejuif, France

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

8512

引用

页数：1